Annual Short Term Debt
$83.70 M
-$5.70 M-6.38%
31 December 2023
Summary:
Vertex Pharmaceuticals Incorporated annual short term debt is currently $83.70 million, with the most recent change of -$5.70 million (-6.38%) on 31 December 2023. During the last 3 years, it has risen by +$41.30 million (+97.41%). VRTX annual short term debt is now -73.80% below its all-time high of $319.43 million, reached on 31 December 2016.VRTX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
N/A
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated quarterly short term debt is not available.VRTX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRTX Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.4% | - |
| 3 y3 years | +97.4% | - |
| 5 y5 years | +1487.9% | - |
VRTX Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -6.4% | +97.4% | ||
| 5 y | 5 years | -6.4% | +1487.9% | ||
| alltime | all time | -73.8% |
Vertex Pharmaceuticals Incorporated Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $83.70 M(-6.4%) | $83.70 M(-6.4%) |
| Dec 2022 | $89.40 M(+11.5%) | $89.40 M(+11.5%) |
| Dec 2021 | $80.20 M(+89.2%) | $80.20 M(+89.2%) |
| Dec 2020 | $42.40 M(+9.3%) | $42.40 M(+9.3%) |
| Dec 2019 | $38.79 M(+636.0%) | $38.79 M(+636.0%) |
| Dec 2018 | $5.27 M(-76.6%) | $5.27 M(-54.2%) |
| Sept 2018 | - | $11.51 M(-23.6%) |
| June 2018 | - | $15.06 M(-11.0%) |
| Mar 2018 | - | $16.92 M(-24.9%) |
| Dec 2017 | $22.53 M(-92.9%) | $22.53 M(+13.3%) |
| Sept 2017 | - | $19.88 M(+9.4%) |
| June 2017 | - | $18.18 M(-5.7%) |
| Mar 2017 | - | $19.27 M(-94.0%) |
| Dec 2016 | $319.43 M(+267.8%) | $319.43 M(+1.2%) |
| Sept 2016 | - | $315.52 M(+32.0%) |
| June 2016 | - | $239.02 M(+46.2%) |
| Mar 2016 | - | $163.54 M(+88.3%) |
| Dec 2015 | $86.84 M(+171.3%) | $86.84 M(+513.6%) |
| Sept 2015 | - | $14.15 M(-75.1%) |
| June 2015 | - | $56.79 M(+17.8%) |
| Mar 2015 | - | $48.20 M(+50.6%) |
| Dec 2014 | $32.01 M(+89.5%) | $32.01 M(+76.6%) |
| Sept 2014 | - | $18.12 M(-8.0%) |
| June 2014 | - | $19.71 M(+7.6%) |
| Mar 2014 | - | $18.32 M(+8.5%) |
| Dec 2013 | $16.89 M(+23.2%) | $16.89 M(+17.1%) |
| Sept 2013 | - | $14.43 M(+35.3%) |
| June 2013 | - | $10.66 M(+28.5%) |
| Mar 2013 | - | $8.30 M(-39.4%) |
| Dec 2012 | $13.71 M(>+9900.0%) | $13.71 M(>+9900.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2011 | - | $98.42 M(+4.0%) |
| June 2011 | - | $94.66 M(+2.8%) |
| Mar 2011 | - | $92.10 M(-32.8%) |
| Dec 2010 | $136.99 M(+327.1%) | $136.99 M(>+9900.0%) |
| Sept 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(-100.0%) |
| Dec 2009 | $32.07 M(>+9900.0%) | $32.07 M(>+9900.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2007 | $20.00 M(-80.7%) | $20.00 M(0.0%) |
| Sept 2007 | - | $20.00 M(-67.8%) |
| June 2007 | - | $62.10 M(+37.3%) |
| Mar 2007 | - | $45.23 M(-56.4%) |
| Dec 2006 | $103.76 M | $103.76 M(+146.4%) |
| Sept 2006 | - | $42.10 M(+798.1%) |
| Sept 2004 | - | $4.69 M(0.0%) |
| June 2004 | - | $4.69 M(>+9900.0%) |
| Mar 2004 | - | $36.00 K(-99.3%) |
| Sept 2003 | - | $4.84 M(+38.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2003 | - | $3.49 M(+154.0%) |
| Mar 2003 | - | $1.37 M(-37.4%) |
| Dec 2002 | $2.19 M(-52.1%) | $2.19 M(-26.1%) |
| Sept 2002 | - | $2.97 M(-15.6%) |
| June 2002 | - | $3.52 M(-10.4%) |
| Mar 2002 | - | $3.93 M(-14.2%) |
| Dec 2001 | $4.58 M(-9.7%) | $4.58 M(+0.4%) |
| Sept 2001 | - | $4.56 M(+126.3%) |
| June 2001 | - | $2.02 M(-7.8%) |
| Mar 2001 | - | $2.19 M(-56.9%) |
| Dec 2000 | $5.07 M(+114.3%) | $5.07 M(-96.9%) |
| Sept 2000 | - | $163.80 M(+7331.9%) |
| June 2000 | - | $2.20 M(-3.0%) |
| Mar 2000 | - | $2.27 M(-4.0%) |
| Dec 1999 | $2.37 M(-15.5%) | $2.37 M(-5.4%) |
| Sept 1999 | - | $2.50 M(-3.8%) |
| June 1999 | - | $2.60 M(-3.7%) |
| Mar 1999 | - | $2.70 M(-3.6%) |
| Dec 1998 | $2.80 M(+12.0%) | $2.80 M(0.0%) |
| Sept 1998 | - | $2.80 M(+3.7%) |
| June 1998 | - | $2.70 M(+8.0%) |
| Mar 1998 | - | $2.50 M(0.0%) |
| Dec 1997 | $2.50 M(-13.8%) | $2.50 M(-7.4%) |
| Sept 1997 | - | $2.70 M(-3.6%) |
| June 1997 | - | $2.80 M(0.0%) |
| Mar 1997 | - | $2.80 M(-3.4%) |
| Dec 1996 | $2.90 M(+38.1%) | $2.90 M(+16.0%) |
| Sept 1996 | - | $2.50 M(+8.7%) |
| June 1996 | - | $2.30 M(+9.5%) |
| Mar 1996 | - | $2.10 M(0.0%) |
| Dec 1995 | $2.10 M(+23.5%) | $2.10 M(+10.5%) |
| Sept 1995 | - | $1.90 M(+5.6%) |
| June 1995 | - | $1.80 M(+5.9%) |
| Mar 1995 | - | $1.70 M(0.0%) |
| Dec 1994 | $1.70 M(-5.6%) | $1.70 M(+6.3%) |
| Sept 1994 | - | $1.60 M(0.0%) |
| June 1994 | - | $1.60 M(0.0%) |
| Mar 1994 | - | $1.60 M(-11.1%) |
| Dec 1993 | $1.80 M(0.0%) | $1.80 M(-5.3%) |
| Sept 1993 | - | $1.90 M(-5.0%) |
| June 1993 | - | $2.00 M(+5.3%) |
| Mar 1993 | - | $1.90 M(+5.6%) |
| Dec 1992 | $1.80 M(+50.0%) | $1.80 M(+5.9%) |
| Sept 1992 | - | $1.70 M(+13.3%) |
| June 1992 | - | $1.50 M(+15.4%) |
| Mar 1992 | - | $1.30 M(+8.3%) |
| Dec 1991 | $1.20 M(+50.0%) | $1.20 M(+9.1%) |
| Sept 1991 | - | $1.10 M(+10.0%) |
| June 1991 | - | $1.00 M(+25.0%) |
| Dec 1990 | $800.00 K | $800.00 K |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual short term debt?
- What is the all time high annual short term debt for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual short term debt year-on-year change?
- What is the all time high quarterly short term debt for Vertex Pharmaceuticals Incorporated?
What is Vertex Pharmaceuticals Incorporated annual short term debt?
The current annual short term debt of VRTX is $83.70 M
What is the all time high annual short term debt for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual short term debt is $319.43 M
What is Vertex Pharmaceuticals Incorporated annual short term debt year-on-year change?
Over the past year, VRTX annual short term debt has changed by -$5.70 M (-6.38%)
What is the all time high quarterly short term debt for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly short term debt is $319.43 M